[ESC/EAS Guidelines for the management of dyslipidaemias].

Reiner Ž.; Catapano AL.; De Backer G.; Graham I.; Taskinen M-R.; Wiklund O.; Agewall S.; Alegría E.; Chapman MJ.; Durrington P.; Erdine S.; Halcox J.; Hobbs RH.; Kjekshus JK.; Perrone Filardi P.; Riccardi G.; Storey RF.; David W.; Clinical Practice Guidelines Committee of the Spanish Society of Cardiology None.

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

[ESC/EAS Guidelines for the management of dyslipidaemias].

Reiner Ž., Catapano AL., De Backer G., Graham I., Taskinen M-R., Wiklund O., Agewall S., Alegría E., Chapman MJ., Durrington P., Erdine S., Halcox J., Hobbs RH., Kjekshus JK., Perrone Filardi P., Riccardi G., Storey RF., David W., Clinical Practice Guidelines Committee of the Spanish Society of Cardiology None.

Original publication

DOI

10.1016/j.recesp.2011.09.014

Type

Journal article

Journal

Rev Esp Cardiol

Publication Date

12/2011

Volume

Pages

1168.e1 - 1168.e60

Keywords

Algorithms, Cardiovascular Diseases, Dyslipidemias, Goals, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypolipidemic Agents, Lipids, Risk Assessment, Spain